ATE122235T1 - Staupevirus-impfstoff. - Google Patents

Staupevirus-impfstoff.

Info

Publication number
ATE122235T1
ATE122235T1 AT88301296T AT88301296T ATE122235T1 AT E122235 T1 ATE122235 T1 AT E122235T1 AT 88301296 T AT88301296 T AT 88301296T AT 88301296 T AT88301296 T AT 88301296T AT E122235 T1 ATE122235 T1 AT E122235T1
Authority
AT
Austria
Prior art keywords
canine distemper
virus
distemper virus
distense
virus vaccine
Prior art date
Application number
AT88301296T
Other languages
English (en)
Inventor
Edmund P Bass
William H Kelsey
Michael D Mcfarland
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21817338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE122235(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ATE122235T1 publication Critical patent/ATE122235T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18461—Methods of inactivation or attenuation
    • C12N2760/18463—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88301296T 1987-03-09 1988-02-17 Staupevirus-impfstoff. ATE122235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2381487A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
ATE122235T1 true ATE122235T1 (de) 1995-05-15

Family

ID=21817338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301296T ATE122235T1 (de) 1987-03-09 1988-02-17 Staupevirus-impfstoff.

Country Status (6)

Country Link
EP (2) EP0282179B1 (de)
JP (1) JPS63277633A (de)
AT (1) ATE122235T1 (de)
CA (1) CA1337268C (de)
DE (1) DE3853736T2 (de)
ZA (1) ZA881239B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4136900C1 (de) * 1991-11-09 1993-07-29 Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De
ZA93216B (en) * 1992-01-17 1993-08-18 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant.
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP1280520B2 (de) 2000-05-10 2018-03-21 Novartis AG Pulver auf basis von phospholipiden zur wirkstoffverabreichung
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4545987A (en) * 1983-12-20 1985-10-08 Advanced Genetics Research Institute Psoralen inactivated double-stranded RNA viral vaccines

Also Published As

Publication number Publication date
EP0506147A3 (de) 1992-10-21
EP0282179A2 (de) 1988-09-14
CA1337268C (en) 1995-10-10
DE3853736D1 (de) 1995-06-14
DE3853736T2 (de) 1995-09-28
EP0506147A2 (de) 1992-09-30
AU614735B2 (en) 1991-09-12
JPS63277633A (ja) 1988-11-15
ZA881239B (en) 1988-08-17
EP0282179B1 (de) 1995-05-10
EP0282179A3 (en) 1990-01-31
AU1176088A (en) 1988-09-08

Similar Documents

Publication Publication Date Title
FI943171A (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
ES8705764A1 (es) Procedimiento fotodinamico de inactivacion de virus
DE3853736D1 (de) Staupevirus-Impfstoff.
NZ192477A (en) Method for protecting dogs against virulent canine parvovirus using inactivated virus vaccine
ES2164074T3 (es) Vacunas de virus de la hepatitis a.
ES2123048T3 (es) Analogos de nucleosidos antiviricos.
DK0848615T3 (da) Muilti-undertyoe-FIV-vacciner
ES498752A0 (es) Un procedimiento para preparar una vacuna de virus vivos de la peritonitis infecciosa de los felinos
HU9202976D0 (en) Vaccine acting against anaemy of chicken
DZ1550A1 (fr) Vaccin depourvu de cellules contre le virus de la maladie marek.
ES2095477T3 (es) Metodo para detectar dosis de radiacion utilizando material termoluminiscente.
ES2068883T3 (es) Vacunas combinadas vivas.
ES8202357A1 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
ES2055610T3 (es) Vacuna contra hrsv.
DK0485463T3 (da) Svækket hundeparvovirus (CPV), vaccine omfattende CPV og fremgangsmåde til forebyggelse af CPV-infektion i hunde
NL300073I1 (nl) Vaccin.
ATE18007T1 (de) Hepatitisimpfstoff.
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
Felfe et al. Trends in production of foot-and-mouth disease vaccine.
RU94031386A (ru) Вакцина сухая культуральная против вирусного энтерита гусей и способ профилактики и лечения вирусного энтерита гусей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties